In 2006, The Center for Medical Genetics was the third largest source of external research funding at the NorthShore University HealthSystem Research Institute. Among the 7 NorthShore University HealthSystem (NorthShore) priority areas for research, medical genetics is in the top 3 with 4.4 million dollars in annualized external funding.
National Institutes of Health (NIH)
The NIH is part of the Department of Health and Human Services (DHHS); the NIH is the primary federal agency established to support and conduct medical research. NIH funding supports faculty research ranging from career development to gene discovery and advancing medical care.
With $19 million per year in NIH grants, NorthShore is in the top 5% of all institutions that receive funding from the National Institutes of Health.
NIH ranked NorthShore as #20 in the nation for independent research hospitals.
The National Cancer Institute (NCI) coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients. The National Cancer Institute funds The Center for Medical Genetics’ microarray breast cancer studies.
The National Human Genome Research Institute (NHGRI) led the NIH contribution to the International Human Genome Project, which had as its primary goal the sequencing of the human genome. Now, the NHGRI's mission has expanded to encompass a broad range of studies aimed at understanding the structure and function of the human genome and its role in health and disease. The NHGRI provides substantial funding to support the mission of the NorthShore University HealthSystem Center for Functional Genomics.
The National Institute of Mental Health (NIMH) reduces the burden of mental illness and behavioral disorders through research on mind, brain, and behavior. The National Institute of Mental Health granted one of its largest funding awards to support the NorthShore University HealthSystem Center for Genetics in Psychiatry for ongoing research in the genetics of schizophrenia.
Centers for Disease Control and Prevention (CDC)
The CDC protects the health and safety of all Americans and provides essential human services, especially for those people who are least able to help themselves. The CDC has partnered with the Association for Prevention Teaching and Research (ATPR) to provide the Center for Medical Genetics a cooperative grant of 1.7 million dollars to evaluate the Family HealthwareTM software developed by the CDC to assess family health history.
Department of Defense Breast Cancer Research Fund
The Department of Defense Breast Cancer Research Fund provides funds to the NorthShore University HealthSystem Center for Functional Genomics for breast cancer research initiatives.
Susan G. Komen Breast Cancer Foundation
The Susan G. Komen Breast Cancer Foundation is committed to eradicating breast cancer as a life-threatening disease. Through funding of programs like the Komen Foundation Award and Research Grant Program and the Komen Affiliate Grant Program, the Foundation has become a worldwide leader in the fight against breast cancer. Former Komen grantees include, Mary Claire King, Ph.D., who discovered the gene mutation BRCA1, an indicator for inherited forms of breast cancer. The Foundation has awarded the Center for Medical Genetics $250,000 over 2 years to conduct microarray breast cancer research for susceptibility genes.
Chicago Biomedical Consortium
The mission of the Chicago Biomedical Consortium is to stimulate collaboration among scientists at Northwestern University, the University of Chicago, and the University of Illinois at Chicago that will transform research at the frontiers of biomedicine. The Chicago Biomedical Consortium funds the NorthShore University HealthSystem Center for Functional Genomics in research initiatives related to the genomic causes of cancer.
Gynecologic Oncology Group (GOG)
The GOG is a non-profit organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of Gynecologic malignancies. The GOG provides funding to the Center for Medical Genetics in support of a nationwide, multi-institution, prospective cohort study of women at increased genetic risk of ovarian cancer. The GOG-0199 prospective study is a collaboration between the Clinical Genetics Branch of NCI’s Intramural Research Program, the Gynecologic Oncology Group and the Cancer Genetics Network.